Using a murine multistep chemical carcinogenesis model of squamous cell carcinoma, Alitalo et al. demonstrated that VEGF-C/VEGF-D-blocking agents inhibit inflammatory skin carcinogenesis. Here, VEGFC is linked to squamous cell carcinoma.